Related Experiment Video

Updated: Aug 20, 2026

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase
09:51

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase

Published on: June 30, 2023

Catalytic site-specific inhibition of the 20S proteasome by 4-hydroxynonenal

Deborah A Ferrington1, Rebecca J Kapphahn

  • 1Department of Ophthalmology, University of Minnesota, Minneapolis, MN 55455, USA. ferri013@umn.edu

FEBS Letters
|December 14, 2004
PubMed

Insights

4-hydroxynonenal (HNE) rapidly inhibits the proteasome's chymotrypsin-like activity. This study identifies the alpha 6/C2 subunit as uniquely modified, revealing molecular details of proteasome inhibition by HNE.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cellular Biology

Background:

  • The proteasome is a crucial cellular machine for protein degradation, essential for cell survival.
  • Oxidative stress, mediated by compounds like 4-hydroxynonenal (HNE), can impair proteasome function.
  • Understanding proteasome inhibition mechanisms is vital for cellular health research.

Purpose of the Study:

  • To investigate the rapid inhibitory effects of 4-hydroxynonenal (HNE) on the 20S proteasome.
  • To identify specific proteasome subunits modified by HNE.
  • To elucidate the molecular basis of HNE-induced, site-specific proteasome inhibition.

Main Methods:

  • Purification of the 20S proteasome from liver tissue.
  • Assay of chymotrypsin-like proteasome activity following HNE treatment.
  • Identification of HNE-modified subunits using 2D gel electrophoresis, Western immunoblotting, and MALDI-TOF MS.

Main Results:

  • HNE was found to rapidly inhibit the chymotrypsin-like activity of the purified 20S proteasome.
  • The alpha 6/C2 subunit was uniquely identified as containing HNE-adducts when chymotrypsin-like activity was specifically inhibited.
  • These findings pinpoint a specific subunit modification linked to catalytic activity inhibition.

Conclusions:

  • HNE directly and rapidly inhibits the chymotrypsin-like activity of the 20S proteasome.
  • The alpha 6/C2 subunit is a key target for HNE-mediated proteasome inhibition.
  • This research provides critical molecular insights into the catalytic site-specific inhibition of proteasomes by oxidants like HNE.

More Related Videos

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

Anaerobic Protein Purification and Kinetic Analysis via Oxygen Electrode for Studying DesB Dioxygenase Activity and Inhibition08:31

Anaerobic Protein Purification and Kinetic Analysis via Oxygen Electrode for Studying DesB Dioxygenase Activity and Inhibition

Published on: October 3, 2018

Related Concept Videos

The Proteasome Structure01:17

The Proteasome Structure

The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Enzymes02:34

Enzymes

Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.